INVO Bioscience, Inc. has been granted an extension to demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) until November 20, 2023, and the date for the company's 2023 annual meeting of shareholders has been set for November 16, 2023.
AI Assistant
INVO FERTILITY INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.